Ginkgo Bioworks Holdings (DNA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NYSE
Market Cap: $622.97M
Last updated: Nov 17, 2026 at 11:03 AM ET
Ginkgo Bioworks Holdings (DNA) Government Contracts
Federal agencies obligated $26.59M to Ginkgo Bioworks Holdings over the 12 months through Jul 31, 2026, down 60.5% from the prior 12 months. Department of Health and Human Services was the top awarding agency with 95.8% of obligations across 2 agencies. Ginkgo Bioworks Holdings had obligation activity on 4 federal contracts over the same 12 months, including 1 new contract.
Federal Obligations
Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated.
- Obligations
- $26.59M
- Change
- -60.5%
- Obligations to revenue
- 17.6%
| Prior 12 months | $67.34M |
|---|---|
| Contracts with activity | 4 |
| New contracts | 1 |
| Top agency | Department of Health and Human Services |
| Top agency share | 95.8% |
|---|---|
| Agencies | 2 |
| Average remaining term | 17.9 months |
12 months through Jul 31, 2026
Largest New Awards
| Award ID | Agency | Amount | Start | End | Description |
|---|---|---|---|---|---|
| 75D30126F00004 | Centers for Disease Control and Prevention | $3.20M | May 3, 2026 | Apr 14, 2028 | METAGENOMIC NEXT-GENERATION SEQUENCING (MNGS) |
Monthly Obligations
The latest complete month, Apr 2026, had no net obligations. The largest month in the table was Aug 2024, at $54.51M.
| Month | Obligations |
|---|---|
| Jul 2026 | $0 |
| Jun 2026 | $0 |
| May 2026 | $3.20M |
| Apr 2026 | $0 |
| Mar 2026 | $21M |
| Feb 2026 | $0 |
| Jan 2026 | $0 |
| Dec 2025 | $0 |
| Nov 2025 | $0 |
| Oct 2025 | $0 |
| Sep 2025 | $1.71M |
| Aug 2025 | $676,131 |
| Month | Obligations |
|---|---|
| Jul 2025 | -$135,434 |
| Jun 2025 | $1.12M |
| May 2025 | $0 |
| Apr 2025 | $0 |
| Mar 2025 | $0 |
| Feb 2025 | $68,090 |
| Jan 2025 | $54.18M |
| Dec 2024 | -$53.60M |
| Nov 2024 | $0 |
| Oct 2024 | $0 |
| Sep 2024 | $11.21M |
| Aug 2024 | $54.51M |
Net obligations recorded each month, newest first. Agencies report contract actions with a delay (the Defense Department about 90 days), so the latest months, May to Jul 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.
Frequently Asked Questions About DNA
How much does Ginkgo Bioworks Holdings receive in federal contracts?
Ginkgo Bioworks Holdings had $26.59M in federal contract obligations over the 12 months through Jul 31, 2026, compared with $67.34M in the 12 months before, down 60.5%. Obligations are contract bookings by the awarding agency, not recognized revenue.
What are Ginkgo Bioworks Holdings' largest government contracts?
The largest new awards over the 12 months through Jul 31, 2026 were 75D30126F00004, Department of Health and Human Services, $3.20M, started May 3, 2026.
Which agencies award Ginkgo Bioworks Holdings contracts?
Department of Health and Human Services was the top awarding agency with 95.8% of obligations over the 12 months through Jul 31, 2026. The records cover 2 agencies.
What new federal contracts did Ginkgo Bioworks Holdings win in the 12 months through Jul 31, 2026?
Ginkgo Bioworks Holdings won 1 new federal contract in the 12 months through Jul 31, 2026. The largest was 75D30126F00004, Department of Health and Human Services, $3.20M, started May 3, 2026.
How do Ginkgo Bioworks Holdings' federal obligations compare with its revenue?
Federal contract obligations were $26.59M over the 12 months through Jul 31, 2026, equivalent to 17.6% of Ginkgo Bioworks Holdings' revenue. Obligations are amounts the government committed to contracts in the period, not the share of Ginkgo Bioworks Holdings' revenue that comes from the government.
DNA pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts